S Gamerman1, A M Singh, M Makhija, A Sharathkumar. Show Affiliations » 1. Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL.
Abstract
Entities: Chemical Disease Species
Mesh： See more » Antibodies, Monoclonal, Murine-Derived/metabolismAntibodies, Monoclonal, Murine-Derived/therapeutic useBlood Coagulation Factor Inhibitors/antagonists & inhibitorsBlood Coagulation Factor Inhibitors/bloodBlood Coagulation Factors/therapeutic useCoagulants/therapeutic useDesensitization, ImmunologicFactor IX/analysisFactor VIIa/therapeutic useHalf-LifeHemophilia B/bloodHemophilia B/complicationsHemophilia B/drug therapyHumansImmunologic Factors/metabolismImmunologic Factors/therapeutic useInfantIntracranial Hemorrhages/drug therapyIntracranial Hemorrhages/etiologyMaleRecombinant Proteins/therapeutic useRituximab
Substances： See more » Antibodies, Monoclonal, Murine-DerivedBlood Coagulation Factor InhibitorsBlood Coagulation FactorsCoagulantsImmunologic FactorsRecombinant Proteinsprothrombin complex concentratesRituximabFactor IXrecombinant FVIIaFactor VIIa
Year: 2013 PMID： 23992223 DOI： 10.1111/hae.12238
Source DB: PubMed Journal: Haemophilia ISSN： 1351-8216 Impact factor: 4.287